文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Pediatric Gaucher Disease Presenting with Massive Splenomegaly and Hepatic Gaucheroma.

作者信息

Bossù Gianluca, Pedretti Laura, Bertolini Lorenzo, Esposito Susanna

机构信息

Pediatric Clinic, Department of Medicine and Surgery, University Hospital of Parma, 43126 Parma, Italy.

Unit of Radiologic Sciences, Department of Medicine and Surgery, University Hospital of Parma, 43126 Parma, Italy.

出版信息

Children (Basel). 2023 May 12;10(5):869. doi: 10.3390/children10050869.


DOI:10.3390/children10050869
PMID:37238417
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10216919/
Abstract

Gaucher Disease (GD) is a condition resulting from an autosomal recessive inheritance pattern, characterized by a deficiency of the lysosomal enzyme beta-glucocerebrosidase. This leads to the accumulation of glucocerebroside and other glycolipids in multiple tissues, causing damage to various organ systems. The diagnosis of GD can be challenging due to its heterogeneity, non-specific symptoms, and variability across different geographic regions and age groups. Although GD is suspected based on symptoms or signs, the diagnosis is confirmed through the measurement of deficient b-glucocerebrosidase activity and the identification of biallelic pathogenic variants in the gene. Intravenous enzyme replacement therapy (ERT) is recommended for GD patients. In this paper, we report a case of a 2-year and 8-month-old girl with massive splenomegaly and radiological finding of hepatic gaucheroma, in whom a genetic study showed homozygous mutation on the gene at c.1448T>C (p.Leu483Pro) and certified the diagnosis of GD. This patient represents the youngest child reported to have gaucheroma and also the first one presenting with gaucheroma at the diagnosis and not during the follow up, highlighting that GD should be routinely included in the differential diagnosis of children presenting with splenomegaly and hepatomegaly, taking into account that the early start of ERT can change the natural history of the disease-preventing serious complications.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23fc/10216919/62718229d798/children-10-00869-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23fc/10216919/62718229d798/children-10-00869-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23fc/10216919/62718229d798/children-10-00869-g001.jpg

相似文献

[1]
Pediatric Gaucher Disease Presenting with Massive Splenomegaly and Hepatic Gaucheroma.

Children (Basel). 2023-5-12

[2]
Very rare condition of multiple Gaucheroma: A case report and review of the literature.

Mol Genet Metab Rep. 2019-7-12

[3]
Very rare condition of multiple Gaucheroma: A case report and review of the literature.

Mol Genet Metab Rep. 2019-5-9

[4]
Genotype/phenotype relationship in Gaucher disease patients. Novel mutation in glucocerebrosidase gene.

Clin Chem Lab Med. 2020-6-25

[5]
Histologic and ultrastructural study of intracranial Gaucheroma causing deafness in a patient with Gaucher disease type 3: Effects of substrate reduction therapy.

Mol Genet Metab Rep. 2024-6-14

[6]
A case of gaucher disease with a rare complication of gaucheroma and protein-losing enteropathy.

Mol Genet Metab Rep. 2024-3-26

[7]
Splenic Gaucheroma Leading to Incidental Diagnosis of Gaucher Disease in a 46-Year-Old Man with a Rare GBA Mutation: A Case Report.

Endocr Metab Immune Disord Drug Targets. 2023

[8]
Gaucher disease in Montenegro - genotype/phenotype correlations: Five cases report.

World J Clin Cases. 2019-6-26

[9]
Gaucher Disease: Identification and Novel Variants in Mexican and Spanish Patients.

Arch Med Res. 2021-10

[10]
Gaucher Disease: One of the Few Causes of Massive Splenomegaly.

Eur J Case Rep Intern Med. 2022-12-19

引用本文的文献

[1]
A review on Gaucher disease: therapeutic potential of β-glucocerebrosidase-targeted mRNA/saRNA approach.

Int J Biol Sci. 2024-3-17

[2]
Adult type I Gaucher disease with splenectomy caused by a compound heterozygous GBA1 mutation in a Chinese patient: a case report.

Ann Hematol. 2024-5

[3]
Noninvasive DBS-Based Approaches to Assist Clinical Diagnosis and Treatment Monitoring of Gaucher Disease.

Biomedicines. 2023-9-29

本文引用的文献

[1]
Patient centered guidelines for the laboratory diagnosis of Gaucher disease type 1.

Orphanet J Rare Dis. 2022-12-21

[2]
Update of treatment for Gaucher disease.

Eur J Pharmacol. 2022-7-5

[3]
The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here?

Mol Genet Metab. 2022-5

[4]
Large Mesenteric Gaucheroma Responds to Substrate Reduction Therapy: A New Management of Gaucheromas.

J Pediatr Genet. 2020-7-29

[5]
Gaucher Disease Diagnosis Using Lyso-Gb1 on Dry Blood Spot Samples: Time to Change the Paradigm?

Int J Mol Sci. 2022-1-30

[6]
Splenomegaly in Children and Adolescents.

Front Pediatr. 2021-7-9

[7]
Throwing a spotlight on under-recognized manifestations of Gaucher disease: Pulmonary involvement, lymphadenopathy and Gaucheroma.

Mol Genet Metab. 2021-8

[8]
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral Venglustat in Healthy Volunteers.

Clin Pharmacol Drug Dev. 2021-1

[9]
The definition of neuronopathic Gaucher disease.

J Inherit Metab Dis. 2020-9

[10]
Very rare condition of multiple Gaucheroma: A case report and review of the literature.

Mol Genet Metab Rep. 2019-5-9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索